Skip to main content

Research Repository

Advanced Search

Inhibition of influenza H5N1 invasion by modified heparin derivatives

Skidmore, Mark A.; Kajaste-Rudnitski, Anna; Wells, Nicola M.; Guimond, Scott E.; Rudd, Timothy R.; Yates, Edwin A.; Vicenzi, Elisa

Authors

Anna Kajaste-Rudnitski

Nicola M. Wells

Timothy R. Rudd

Edwin A. Yates

Elisa Vicenzi



Abstract

Influenza remains a serious health threat, with resistance to frontline drugs becoming more common, and new treatments urgently sought. One strategy for the inhibition of the attachment of influenza to host cells is to employ chemically modified heparins, capable of effectively competing with the multivalent interactions involved. In an assay of H5N1 influenza viral invasion comprising a H5 pseudotyped HIV system, selective removal of the sulfate groups from heparin (IC50 ~22 × 10−9 g mL−1) allowed the retention of inhibitory activity in the products (IC50 ~4 × 10−9 g mL−1) while significantly reducing their anticoagulant activities. Chemically modified anionic polysaccharides offer a potential source of effective inhibitors of viral attachment, which are suitable for further optimisation.

Citation

Skidmore, M. A., Kajaste-Rudnitski, A., Wells, N. M., Guimond, S. E., Rudd, T. R., Yates, E. A., & Vicenzi, E. Inhibition of influenza H5N1 invasion by modified heparin derivatives. MedChemComm, 6(4), 640-646. https://doi.org/10.1039/c4md00516c

Journal Article Type Article
Deposit Date May 31, 2023
Journal MedChemComm
Print ISSN 2040-2503
Electronic ISSN 2040-2511
Publisher Royal Society of Chemistry
Peer Reviewed Peer Reviewed
Volume 6
Issue 4
Pages 640-646
DOI https://doi.org/10.1039/c4md00516c
Keywords Pharmaceutical Science; Biochemistry; Drug Discovery; Molecular Medicine; Pharmacology; Organic Chemistry
Additional Information : This document is Similarity Check deposited; : Supplementary Information; : The Royal Society of Chemistry has an exclusive publication licence for this journal; OPEN ACCESS: The accepted version of this article will be made freely available after a 12 month embargo period; : Single-blind; : Received 12 November 2014; Accepted 19 December 2014; Accepted Manuscript published 23 December 2014; Advance Article published 7 January 2015; Version of Record published 10 April 2015